INNOVATE Corp. Announces Fourth Quarter and Full Year 2024 Results

- Infrastructure: DBM Global fourth quarter revenue of $225.7 million -
- Life Sciences: MediBeacon^® Transdermal GFR (“TGFR”) system received FDA approval to assess kidney function -
- Spectrum: Broadcasting achieved double-digit revenue growth in the fourth quarter and full year 2024 -

Read more at globenewswire.com